TRST.TO - CannTrust Holdings Inc.

Toronto - Toronto Delayed Price. Currency in CAD
6.79
-0.22 (-3.14%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close7.01
Open7.03
Bid6.78 x 0
Ask6.85 x 0
Day's Range6.78 - 7.05
52 Week Range5.86 - 12.64
Volume368,157
Avg. Volume681,168
Market Cap704.924M
BetaN/A
PE Ratio (TTM)30.45
EPS (TTM)0.22
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.15
  • CannTrust Goes West! - CannTrust's Three Recreational Supply Agreements in Western Canada projected to exceed 17,000kg annually
    CNW Group8 days ago

    CannTrust Goes West! - CannTrust's Three Recreational Supply Agreements in Western Canada projected to exceed 17,000kg annually

    VAUGHAN, ON, July 13, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST), one of Canada's leading licensed producers of cannabis, explodes into the adult use market with its first three recreational cannabis supply agreements. Far surpassing CannTrust's initial sales projections, combined agreements from British Columbia, Alberta and Manitoba for CannTrust's high-quality, standardized cannabis under three recreational brands – Liiv, SYNR.G and Xscape – are projected to exceed 17,000 kilograms annually. The broad range of products include dried flower, pre-rolled joint, oil and capsules.

  • CNW Group10 days ago

    CannTrust and Australia's Gold Coast University Hospital partner in ALS clinical trial

    VAUGHAN, ON, July 11, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST), one of Canada's leading licensed producers of medical cannabis, announced today that it has partnered with Australia's Gold Coast University Hospital ("Gold Coast") to conduct a randomized, double-blind, placebo-controlled clinical trial to determine the efficacy of CannTrust cannabidiol (CBD) oil capsules in slowing the disease progression in patients with Amyotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND). Patient safety and tolerability will also be assessed.

  • CNW Group15 days ago

    CannTrust Continues Global Expansion as Danish Partner, STENOCARE, Receives License to Distribute CannTrust Products

    VAUGHAN, ON, July 6, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX:TRST.TO - News), one of Canada's leading licensed producers of cannabis, today announced that its Danish Joint Venture Partner STENOCARE has received approval to distribute CannTrust products in Denmark. CannTrust's high-quality, standardized cannabis oils are the first oils approved for Denmark's list of admitted cannabis products and are the only "ready-to-use" oil products available. Medical cannabis became legal in Denmark on January 1, 2018 after a unanimous vote by the Country's parliament.

  • CannTrust Officially Opens 450,000 sq. ft. Cannabis Perpetual Harvest Facility
    CNW Group24 days ago

    CannTrust Officially Opens 450,000 sq. ft. Cannabis Perpetual Harvest Facility

    VAUGHAN, ON, June 26, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX:TRST.TO - News), one of Canada's leading licensed producers of cannabis, today held the official Grand Opening of its Niagara Perpetual Harvest Facility (the "Facility"), the first such facility in Canada. The current annual output from the Facility is estimated at 50,000 kilograms. In addition, the Company has begun construction of an additional fully funded 600,000 sq. ft. expansion, that when completed, will double CannTrust's annual capacity to in excess of 100,000 kilograms.

  • CNW Group25 days ago

    CannTrust Positioned for Rapid Growth as Canada's Cannabis Act Receives Royal Assent

    VAUGHAN, ON, June 26, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX:TRST.TO - News), one of Canada's leading licensed producers of Cannabis, is applauding the granting of Royal Assent to Bill C-45, the Cannabis Act. With Royal Assent received, the legislation legalizing cannabis for adult consumer use has now passed its final official step, and retail sales are to commence on October 17, 2018, as announced by Canada's federal government. CannTrust is excited and well-positioned to enter this new marketplace and has the production capacity and infrastructure together with standardized products with precise label claims indicating the exact dosage, to immediately begin fulfilling adult consumer use market orders on a national level.

  • Is It Time To Buy CannTrust Holdings Inc (TSE:TRST) Based Off Its PE Ratio?
    Simply Wall St.26 days ago

    Is It Time To Buy CannTrust Holdings Inc (TSE:TRST) Based Off Its PE Ratio?

    This analysis is intended to introduce important early concepts to people who are starting to invest and want to better understand how you can grow your money by investing inRead More...

  • GlobeNewswirelast month

    Analysis: Positioning to Benefit within Canopy Growth, Aurora Cannabis, CannTrust, AbbVie, Cronos Group, and Scotts Miracle-Gro — Research Highlights Growth, Revenue, and Consolidated Results

    NEW YORK, June 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy ...

  • CNW Grouplast month

    CannTrust Enters into Partnership with Kwantlen Polytechnic University

    VAUGHAN, ON, June 13, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX:TRST.TO - News), one of Canada's leading licensed producers of medical cannabis, announced the signing of an agreement with Kwantlen Polytechnic University (KPU) to collaborate on the ongoing development of the university's non-academic Cannabis Career Training program. Offered through KPU's Continuing and Professional Studies division, a suite of non-credit cannabis courses were first offered in 2015.

  • CNW Grouplast month

    Canntrust Enters Partnership With Niagara College

    VAUGHAN, ON, June 12, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST), one of Canada's leading licensed producers of medical cannabis, announced the signing of a memorandum of understanding with Niagara College to collaborate in the development of the College's Commercial Cannabis Production (CCP) Graduate Certificate program. The program will strengthen CannTrust's workforce production capabilities and help fill the growing demand for knowledgeable employees in the booming cannabis industry.

  • CNW Group2 months ago

    CannTrust Holdings Inc. Announces Closing of $100,395,000 Bought Deal Financing

    VAUGHAN, ON, June 5, 2018 /CNW/ - CannTrust Holdings Inc. (TSX:TRST.TO - News) ("CannTrust" or the "Company"), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation ("ACMPR") program, today announced that it has closed its previously announced short form prospectus offering, on a bought deal basis, including the full exercise of the over-allotment option.  A total of 11,155,000 units of the Company ("Units") were sold at a price of $9.00 per Unit for aggregate gross proceeds of $100,395,000 (the "Offering"). Each Unit is comprised of one common share of the Company (a "Common Share") and one-half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant").

  • CNW Group2 months ago

    CannTrust's partnership with NexgenRx gains momentum

    VAUGHAN, ON, June 5, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST), one of Canada's leading licensed producers of medical cannabis, is excited to announce that NexgenRx (TSX-V:NXG.V - News), our healthcare plan claims adjudication partner, has secured its first plan sponsor to include cannabis as a benefit under its patient plan. This plan sponsor's expanded benefits plan represents an important step forward as the legal and health frameworks in Canada develop to include the use of cannabis to help a wide range of medical ailments.

  • MedMen lists on CSE, the hot new place for U.S. cannabis companies
    Yahoo Finance Canada2 months ago

    MedMen lists on CSE, the hot new place for U.S. cannabis companies

    U.S.-based cannabis company MedMen is listing on the Canadian Securities Exchange on Tuesday, and they're hardly the first American pot company to do so.

  • Should You Buy CannTrust Holdings Inc (TSE:TRST) At This PE Ratio?
    Simply Wall St.2 months ago

    Should You Buy CannTrust Holdings Inc (TSE:TRST) At This PE Ratio?

    CannTrust Holdings Inc (TSX:TRST) trades with a trailing P/E of 38.4x, which is lower than the industry average of 48x. While this makes TRST appear like a great stock toRead More...

  • CannTrust to Launch Three New Recreational Brands: Liiv™, Synr.g™ and Xscape™
    CNW Group2 months ago

    CannTrust to Launch Three New Recreational Brands: Liiv™, Synr.g™ and Xscape™

    CannTrust® Holdings Inc. ("CannTrust" or the "company", TSX: TRST), one of Canada's leading licensed producers, manufacturers and distributors of cannabis, today announced that it will be entering the recreational cannabis market together with the launch of new Brands. CannTrust will be introducing three dynamic Brands of recreational cannabis, building on its established reputation as the first pharmacist owner/operated producer of medical cannabis in Canada producing quality standardized cannabis products. "Our team has extensive experience in both the Consumer Goods and Alcohol Industries and has applied this knowledge to the cannabis consumer.

  • CNW Group2 months ago

    CannTrust Holdings Inc. Announces Upsize of Previously Announced Offering

    VAUGHAN, ON, May 16, 2018 /CNW/ - CannTrust Holdings Inc. (TSX:TRST.TO - News) ("CannTrust" or the "Company"), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation ("ACMPR") program, today announced that it has entered into a revised agreement with a syndicate of underwriters led by Canaccord Genuity Corp. and GMP Securities L.P. (together the "Co-Lead Underwriters" and, collectively with the syndicate, the "Underwriters"), pursuant to which the Underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 9,700,000 units (the "Units") of the Company at a price of $9.00 per Unit (the "Offering Price") for aggregate gross proceeds of $87,300,000 (the "Offering").

  • CNW Group2 months ago

    CannTrust Holdings Inc. Announces $75 Million Bought Deal Financing

    VAUGHAN, ON, May 15, 2018 /CNW/ - CannTrust Holdings Inc. (TSX:TRST.TO - News) ("CannTrust" or the "Company"), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation ("ACMPR") program, today announced that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. and GMP Securities L.P. (together the "Co-Lead Underwriters" and, collectively with the syndicate, the "Underwriters"), pursuant to which the Underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 8,350,000 units (the "Units") of the Company at a price of $9.00 per Unit (the "Offering Price") for aggregate gross proceeds of $75,150,000 (the "Offering").

  • CNW Group2 months ago

    CannTrust™ reports record revenue for Q1 2018

    VAUGHAN, ON , May 15, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company" | TSX: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis ...

  • FSCWire3 months ago

    NexgenRx and CannTrust Partner to Provide Medical Cannabis Benefit Access and Real Time Adjudication Services to NexgenRx Plan Members

    NEXGENRX INC. ("NexgenRx" or the "Company", TSX-V: NXG) is pleased to announce that it has signed an exclusive agreement with CannTrust Inc. ("CannTrust®"), one of Canada's leading licensed producers of medical cannabis and a wholly-owned subsidiary of CannTrust Holdings Inc. ("CannTrust", TSX: TRST), to create a simple, seamless ordering process for NexgenRx plan members. The agreement is for an initial five (5) year renewable term.

  • Baystreet3 months ago

    Stocks in play: CannTrust Inc.

    Announced that Aleafia Health has made a formalized relationship with CannTrust, which both companies ...

  • CNW Group3 months ago

    Aleafia aligns with CannTrust

    OTC: CAMDF) ("Aleafia") or (the "Company"), is pleased to announce a formalized relationship with CannTrust Inc. (TSX:TRST.TO - News) ("CannTrust"), which both companies feel will be of significant mutual benefit. The companies have entered into a strategic genetic supply agreement through which Aleafia will receive various strains of high-quality starter genetics for its first licensed production facility in Scugog, Ontario, and CannTrust taking the right of first refusal to purchase product from Aleafia. CannTrust has provided starter genetics to Aleafia for cultivation, which is underway at the Aleafia Farms licensed facility.

  • Baystreet3 months ago

    Big Cannabis Seeking Organic Options to Promote Quality Over Quantity

    Among the many conversations regarding the impending legalization of marijuana in Canada and other ...

  • CNW Group3 months ago

    Canntrust® Holdings Launches Cannabis Oil Vegan Hard Shell Capsules

    VAUGHAN, ON, April 18, 2018 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST), one of Canada's leading licensed producers of cannabis, announced that it is expanding its product offerings to include a range of new cannabis oil vegan-based hard shell capsules. The CannTrust cannabis oil capsules are being produced at the Company's 50,000 square foot, state-of-the-art processing, manufacturing and distribution facility in Vaughan, Ontario.  The introduction of the new vegan-based hard shell product line reinforces the Company's commitment to continuous improvement, innovation, quality, patient education and customer service.

  • CNW Group3 months ago

    CannTrust® Enters Veterinary Cannabis Market Through Partnership with Grey Wolf Animal Health

    Grey Wolf is a privately-owned company established in 2015 by respected veterinarian Dr. Ian Sandler and Bloom Burton & Co. Grey Wolf was created to identify and bring to market products that meet the underserved needs of veterinarians and pet owners. It is a specialty animal health company focused on developing, acquiring and in-licensing companion animal health products for the Canadian and Global markets.

  • Newsfile3 months ago

    BTV Launches New Listing Alert on National TV

    Vancouver, British Columbia--(Newsfile Corp. - April 9, 2018) - BTV - Business Television shines the spotlight on new issuers throughout North America with the launch of its New Listing Alert — a national television and digital campaign unparalleled in the market. "We're very excited to offer this new product for both Canadian and US new issuers," said Taylor Thoen, BTV's CEO. "The New Listing Alert also previews our new look as BTV enters its ...

  • CannTrust Holdings Inc. Opens the Market
    CNW Group4 months ago

    CannTrust Holdings Inc. Opens the Market

    TORONTO , March 29, 2018 /CNW/ - Eric Paul , Chief Executive Officer and Director, CannTrust Holdings Inc. (TRST), joined Ungad Chadda, Senior Vice President, Head of Enterprise Corporate Strategy and ...